Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,743
Closed -$351K 186
2018
Q3
$351K Sell
8,743
-373
-4% -$14.9K 0.05% 147
2018
Q2
$350K Sell
9,116
-852
-9% -$31.4K 0.05% 140
2018
Q1
$342K Sell
9,968
-218
-2% -$7.66K 0.05% 149
2017
Q4
$334K Hold
10,186
0.04% 153
2017
Q3
$340K Sell
10,186
-408
-4% -$14.1K 0.05% 150
2017
Q2
$377K Sell
10,594
-545
-5% -$18.4K 0.05% 143
2017
Q1
$342K Buy
+11,139
New +$343K 0.05% 143

Other funds holding QGEN

Gratus Capital's QGEN Position: Q4 2018 in Review

Gratus Capital sold out of Qiagen (QGEN) in Q4 2018, closing a stake of 8,743 shares — an estimated $351K sold.

Gratus Capital first reported a position in QGEN in Q1 2017 and held it in 7 quarters. The position peaked at $377K in Q2 2017. 251 funds tracked by Wall St. Rank hold QGEN as of Q4 2018.

  • Gratus Capital reported no remaining Qiagen position as of Q4 2018 after selling out during the quarter.
  • Gratus Capital sold 8,743 Qiagen shares in Q4 2018, an estimated $351K.
  • Gratus Capital first reported a position in Qiagen in Q1 2017 and held it in 7 quarters.
  • Gratus Capital's Qiagen position peaked at $377K in Q2 2017.
  • 251 funds tracked by Wall St. Rank held Qiagen as of Q4 2018.

Based on Gratus Capital's 13F filing for Q4 2018, filed 13 Feb 2019.